Profil
Jennifer Dudinak served as the Senior Vice President-Global Regulatory Affairs at Celgene Corp.
from 2018 to 2019.
She received her undergraduate and doctorate degrees from Rutgers University, Camden.
Anciens postes connus de Jennifer Dudinak
| Sociétés | Poste | Fin |
|---|---|---|
| CELGENE | General Counsel | 01/10/2019 |
Formation de Jennifer Dudinak
| Rutgers University, Camden | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 1 |
|---|---|
Celgene Corp.
 Celgene Corp. BiotechnologyHealth Technology Celgene Corp. is an integrated global biopharmaceutical company, which engages in the discovery, development and commercialization of therapies for the treatment of cancer and inflammatory diseases. Its primary commercial stage products include Revlimid, Pomalyst, Imnovid, Otezla, Abraxane, and Vidaza. The company was founded by David Stirling and Sol Barer in 1986 and is headquartered in Summit, NJ. | Health Technology |
